SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-18-001117
Filing Date
2018-09-20
Accepted
2018-09-20 16:17:49
Documents
1
Period of Report
2018-09-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_5697.html 4  
1 PRIMARY DOCUMENT doc4_5697.xml 4 6522
  Complete submission text file 0001638599-18-001117.txt   7874
Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
MATHER CHARLES E IV (Reporting) CIK: 0001563422 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 181079649

Mailing Address 8748 TECHNOLOGY WAY RENO NV 89521
Business Address 8748 TECHNOLOGY WAY RENO NV 89521 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences